Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone know what this means?
Hikma Pharm has filed an Inter Partes Review at the USPTO PTAB v $AMRN Amarin patent 8,642,077 "STABLE PHARMACEUTICAL COMPOSITION AND METHODS OF USING SAME"
— IPHawk (@TheIpHawk) December 1, 2021
All i’m saying is it’s a possibility. I think of it this way…
Unless there is some more horrific news on the horizon that we as outsiders cannot foresee, why wouldn’t an exec open his wallet for 10,20,30k shares at this level? Halfway decent execution should double their $ within a year without M&A… something’s been cooking, and obviously i’m not insinuating that it’s undoubtedly positive but I remain optimistic.
In my opinion, this is the ONLY hope that we have left that negotiations have been ongoing… M&A can take years to develop, especially when fundamentals are significantly altered…
Lblegend33
I noticed this as well. He’s probably way too embarrassed to mention Amarin to his twitter following, but he has no shame pumping away on here.
I was thinking similarly the other day. However, my thoughts were more geared towards the BVF / Sarissa relationship. I started to do a bit of digging and got sidetracked. But they have had at least a few mutual positions over the past few years. Could just be coincidental…
The fund owned 5.05 million shares, valued at $36.5 million based on Idenix’s market price before deal announcement.
KM made a reference to this during the investor presentation with Jeffries the other day
Are you able to elaborate ?
North,
We did not hit $26 until December of 2019. Over 1 year after REDUCE-IT results.
Quick search so take these figures are just rough estimates.
Idenix 52 week low prior to getting taken out was 2.93. Not much of a run up in prior two months before acquisition ~high 5’s to mid 7’s (acquired $24.50/ share)
Ariad 52 week low prior to getting taken out was 4.37. Two months prior to that acquisition it was trading around 8.50 and ran up to the ~14 range (acquired $24/ share)
Bioverativ 52 week low prior to getting taken out was 40.99. 2 months prior ran from high 40s to mid 60s. (Acquired $105/share)
Not sure , just googled the acquisition newsletters. Will search old charts in a bit and get back to you.
I’ll take the Idenix premium tomorrow and pack my bags just to put an end to this debacle
Idenix premium over 200%
Ariad premium ~75%
Biovertiv premium ~65%
Ranges from a few quarters to a few years it seems
Denner led the activist campaigns in selling Idenix to Merck, Ariad to Takeda and Bioverativ (a Biogen subsidiary) to Sanofi. There are rumors Ironwood is next up where he has a seat on the board. And lastly, would be our precious Amarin.
Sorry, can you please elaborate?
There are a bunch of bright folks on this board and I can’t understand why you would even consider responding to posters like Cynical. Anyone who has been following the company as close as we have for the better part of the last decade knows developments and execution are trending in the wrong direction. Why give a poster like that any attention? It’s all fear mongering but I guarantee he convinces a few people to exit their position and who really knows who that brave individual is behind that keyboard?
Things are looking grim at the moment, but in all likelihood this will come down to supply. Our hopes and dreams of holding the winning lottery ticket here are probably crushed, but even halfway decent execution over the next year likely results in a double from here. Nothing for most of us to get excited about—barely means break even for me—but beats taking a loss here near 3 year lows.
Wall Street plays dirty dirty games. Whether thats happening here or not is obviously TBD…
LBL? Where art thou? We can use another one of your hopeless predictions! Come on, lead us to believe the buyout is just still under negotiations! Q1 2022 right?
*cue half the board running around like their hair is on fire now that LBL lifted our hopes yet again for a takeover*
Although others may not, I have to say I thoroughly enjoy your sense of humor
I’m guessing there will be a bidding war for this one
I wish!!!
From Bloomberg Article:
Acceleron Is in Advanced Talks for $11 Billion Sale
By Michelle F Davis and Ed Hammond
September 24, 2021, 8:32 PM EDT
Drugmaker Acceleron Pharma Inc. is in advanced discussions to be acquired by a large pharmaceutical company for about $180 a share in cash, according to people familiar with the matter.
The identity of the potential buyer couldn’t be immediately learned. Several global drugmakers, including Bristol-Myers Squibb Co., which owns 11.5% of Acceleron’s stock, are seen as obvious potential suitors, said the people, who asked not to be identified because the information was private.
Likely BMY as they already own 11.5% stake
I tried to look into the Canadian site, couldn’t find it. I remember Pdude mentioning something about meeting with a few people involved with this HLS/Pfizer situation in Canada. So I guess it’s possible he heard about the layoffs through offline conversation.
I’m more interested in the Pfizer layoff rumor. I can’t confirm that anywhere.
Which state are you in and did the pharmacist ask your wife before making the switch?
I haven’t, but we’re probably better off. There’s no clear indication that scripts were positively impacted with those DTC ads. We are in a very unique situation here, rather them save the $ for now.
I could be wildly off base, but the fact not one insider opens their wallet to purchase a few shares on the open market might be the strongest indication negotiations are ongoing. David Stack’s conversions don’t count.
I mean come on, at these levels…
From Raf on StockTwits:
https://stocktwits.com/rafunrafun/message/375750419
Raf couldn’t post any more today but requested this be posted here :
https://stocktwits.com/rafunrafun/message/373728825
I’m setting an alarm just in case I doze off :)
It will be a late night for us, but hopefully worth it ! Cheers!
Pharm
If you’re pulling this info directly from ESC, I believe it automatically adjusts to your time zone. 8 AM presentation in Europe, 2 AM here in EST.
I am NOT 100% sure on this, but this seems to be the consensus and it aligns with how EVAPORATE results were released. Please correct me if I am wrong.
We’ll all know the results at the same time depending on how late us east coast folks want to stay up ;)
I know i’ll be up!
What an exceptional response. This is an IR team!!!!!
I really like how he noted Vascepa will be the primary detailed product...
Anyone know any former Pharma executives that would be able to make sense out of this move by Pfizer ?
Foreshadowing hopefully
Does this work?
Here is the link to the transcript. His discussion on Amarin begins on Page 5
https://www.realvision.com/rv/media/Video/89f7553f8afc413d82766ce5c1f1048f/transcript